137 related articles for article (PubMed ID: 18559726)
1. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):603-7. PubMed ID: 18559726
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
3. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of the retrospective use of the Adult Comorbidity Evaluation index (ACE-27) in patients with cancer of the head and neck who had radiotherapy.
Rogers SN; Aziz A; Lowe D; Husband DJ
Br J Oral Maxillofac Surg; 2006 Aug; 44(4):283-8. PubMed ID: 16107297
[TBL] [Abstract][Full Text] [Related]
5. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
7. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
8. Differential prognostic impact of comorbidity in head and neck cancer.
Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
[TBL] [Abstract][Full Text] [Related]
9. First-year trends in self-reported general health predict survival in patients with head and neck cancer.
Jameson MJ; Karnell LH; Christensen AJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):958-64. PubMed ID: 18794441
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
[TBL] [Abstract][Full Text] [Related]
11. Age as a prognostic factor for complications of major head and neck surgery.
Boruk M; Chernobilsky B; Rosenfeld RM; Har-El G
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):605-9. PubMed ID: 16027283
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of comorbidity in salivary gland carcinoma.
Terhaard CH; van der Schroeff MP; van Schie K; Eerenstein SE; Lubsen H; Kaanders JH; Smeele LE; Burlage FR; van Den Ende PL; Baatenburg de Jong RJ
Cancer; 2008 Oct; 113(7):1572-9. PubMed ID: 18704992
[TBL] [Abstract][Full Text] [Related]
13. Factors that influence treatment decision in older patients with resectable head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Laryngoscope; 2007 May; 117(5):835-40. PubMed ID: 17473679
[TBL] [Abstract][Full Text] [Related]
14. Measuring comorbidity in patients with head and neck cancer.
Hall SF; Rochon PA; Streiner DL; Paszat LF; Groome PA; Rohland SL
Laryngoscope; 2002 Nov; 112(11):1988-96. PubMed ID: 12439168
[TBL] [Abstract][Full Text] [Related]
15. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
16. Assessment of functioning in patients with head and neck cancer according to the International Classification of Functioning, Disability, and Health (ICF): a multicenter study.
Tschiesner U; Linseisen E; Baumann S; Siedek V; Stelter K; Berghaus A; Cieza A
Laryngoscope; 2009 May; 119(5):915-23. PubMed ID: 19358200
[TBL] [Abstract][Full Text] [Related]
17. Using comorbidity indexes to predict costs for head and neck cancer.
Hollenbeak CS; Stack BC; Daley SM; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):24-7. PubMed ID: 17224517
[TBL] [Abstract][Full Text] [Related]
18. Development of a new head and neck cancer-specific comorbidity index.
Piccirillo JF; Lacy PD; Basu A; Spitznagel EL
Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1172-9. PubMed ID: 12365889
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
20. The effect of comorbidity on quality of life during radiotherapy in head and neck cancer.
Oozeer NB; Benbow J; Downs C; Kelly C; Welch A; Paleri V
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):268-72. PubMed ID: 18656727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
